Affordable Access

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

Authors
Type
Published Article
Journal
Journal of Pediatric Surgery
1531-5037
Publisher
Elsevier
Publication Date
Volume
41
Issue
8
Pages
1431–1440
Identifiers
PMID: 16863850
Source
Medline
License
Unknown

Abstract

These findings suggest that TRAIL therapy in combination with specific chemotherapeutic agents may represent an effective therapeutic strategy for NB. The cell's sensitivity to TRAIL is at least partially governed by both TRAIL-R and survivin expression, whereas the ratio between these 2 factors appears to have prognostic value in patients with this disease.

Statistics

Seen <100 times